March 12 (Reuters) - Immutep Ltd IMM.AX :
* ENTERED INTO A CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK & CO., INC
* DEAL TO EVALUATE COMBINATION OF IMMUTEP'S IMMUNOTHERAPY PRODUCT CANDIDATE WITH MSD'S ANTI-PD-1 THERAPY KEYTRUDA IN A NEW CLINICAL TRIAL